Inovio Biomedical Corporationl to Present at Vaccine Technology III Conference

BLUE BELL, Pa.--(BUSINESS WIRE)--Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the chair of its scientific advisory board and its R&D leader will present at Vaccine Technology III, a worldwide scientific and medical conference, being held June 6 - 11, 2010 at the Vallarta Palace Hotel in Nuevo Vallarta, Mexico. Inovio presenters will discuss its SynCon™ DNA vaccine platform and its ability to generate relevant immune responses against emerging infectious diseases.

Back to news